Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.

Cancer cell | 2019

Drug-tolerant "persister" tumor cells underlie emergence of drug-resistant clones and contribute to relapse and disease progression. Here we report that resistance to the BCL-2 targeting drug ABT-199 in models of mantle cell lymphoma and double-hit lymphoma evolves from outgrowth of persister clones displaying loss of 18q21 amplicons that harbor BCL2. Further, persister status is generated via adaptive super-enhancer remodeling that reprograms transcription and offers opportunities for overcoming ABT-199 resistance. Notably, pharmacoproteomic and pharmacogenomic screens revealed that persisters are vulnerable to inhibition of the transcriptional machinery and especially to inhibition of cyclin-dependent kinase 7 (CDK7), which is essential for the transcriptional reprogramming that drives and sustains ABT-199 resistance. Thus, transcription-targeting agents offer new approaches to disable drug resistance in B-cell lymphomas.

Pubmed ID: 31085176 RIS Download

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA211336
  • Agency: NCI NIH HHS, United States
    Id: P01 CA066996
  • Agency: NCI NIH HHS, United States
    Id: P30 CA076292
  • Agency: NCI NIH HHS, United States
    Id: R01 CA179062
  • Agency: NCI NIH HHS, United States
    Id: P50 CA100707
  • Agency: NCI NIH HHS, United States
    Id: R01 CA134807
  • Agency: NCI NIH HHS, United States
    Id: R21 CA234519
  • Agency: NCI NIH HHS, United States
    Id: R01 CA137123

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Gene Set Enrichment Analysis (tool)

RRID:SCR_003199

Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.

View all literature mentions

PANTHER (tool)

RRID:SCR_004869

System that classifies genes by their functions, using published scientific experimental evidence and evolutionary relationships to predict function even in absence of direct experimental evidence. Orthologs view is curated orthology relationships between genes for human, mouse, rat, fish, worm, and fly.

View all literature mentions

MaxQuant (tool)

RRID:SCR_014485

A quantitative proteomics software package for analyzing large-scale mass-spectrometric data sets. It is a set of algorithms that include peak detection and scoring of peptides, mass calibration, database searches for protein identification, protein quantification, and provides summary statistics.

View all literature mentions

Ikaros (D6N9Y) (antibody)

RRID:AB_2744523

This monoclonal targets Ikaros

View all literature mentions

c-Myc antibody [Y69] (antibody)

RRID:AB_731658

This monoclonal targets c-Myc antibody [Y69]

View all literature mentions

β-Actin Antibody (C4) (antibody)

RRID:AB_2714189

This monoclonal targets β-Actin

View all literature mentions

Mcl-1 (S-19) (antibody)

RRID:AB_2144105

This polyclonal targets MCL1

View all literature mentions

Bcl2A1 antibody (antibody)

RRID:AB_1523197

This polyclonal targets Human Bcl2A1

View all literature mentions

Anti-TCF-4 antibody (antibody)

RRID:AB_2801300

This polyclonal targets TCF-4

View all literature mentions

H3K27ac-human (antibody)

RRID:AB_2118291

This polyclonal targets H3K27ac

View all literature mentions

Anti-RNA polymerase II subunit B1 (phospho-CTD Ser-5) Antibody, clone 3E8 (antibody)

RRID:AB_2801296

This monoclonal targets RNA Polymerase II subunit B1 phosphorylated at Ser5 of the C-terminal domain

View all literature mentions

Anti-RNA polymerase II subunit B1 (phospho-CTD Ser-7) Antibody, clone 4E12 (antibody)

RRID:AB_2801298

This monoclonal targets RNA polymerase II subunit B1 phosphorylated at Ser7 of the C-terminal domain

View all literature mentions

Anti-RNA polymerase II subunit B1 (phospho CTD Ser-2), clone 3E10 (antibody)

RRID:AB_10627998

This monoclonal targets RNA polymerase II subunit B1 (phospho CTD Ser-2) clone 3E10

View all literature mentions

CDK7 (MO1) Mouse mAb (antibody)

RRID:AB_2077142

This monoclonal targets CDK7 (MO1) Mouse mAb

View all literature mentions

BCL11A (D4E3P) Rabbit mAb (antibody)

RRID:AB_2799868

This monoclonal targets Bcl-11A

View all literature mentions

Cleaved PARP (Asp214) (D64E10) XP Rabbit mAb (antibody)

RRID:AB_10699459

This monoclonal targets Cleaved PARP (Asp214)

View all literature mentions

Noxa (D8L7U) Rabbit mAb (antibody)

RRID:AB_2798602

This monoclonal targets NOXA

View all literature mentions

FoxC1 (D8A6) Rabbit mAb (antibody)

RRID:AB_2797657

This monoclonal targets FOXC1

View all literature mentions

Bax Antibody (antibody)

RRID:AB_10695870

This polyclonal targets Bax

View all literature mentions

Bcl-2 Antibody (Human Specific) (antibody)

RRID:AB_10693462

This polyclonal targets Bcl-2 (Human Specific)

View all literature mentions

Bak (D4E4) Rabbit mAb (antibody)

RRID:AB_2716685

This monoclonal targets Bak

View all literature mentions

Bim (C34C5) Rabbit mAb (antibody)

RRID:AB_1030947

This monoclonal targets Bim (C34C5) Rabbit mAb

View all literature mentions

HBL-2 [Human mantle cell lymphoma] (cell line)

RRID:CVCL_4216

Cell line HBL-2 [Human mantle cell lymphoma] is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

c-Myc antibody [Y69] (antibody)

RRID:AB_731658

This monoclonal targets c-Myc antibody [Y69]

View all literature mentions